By Hera Rizwan COVID-19 cases in India are rising steadily, with most new infections reported from Maharashtra, Karnataka, ...

The COVID-19 pandemic showed the value of changing direction in research. It should be incentivized, encouraged and ...

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

Remdesivir was associated with a significant survival benefit and reduced risk for rehospitalization among inpatients with COVID-19 infection.

SARS-CoV-2, the virus responsible for Covid-19, has not disappeared, but it no longer behaves like an unpredictable emergency ...

India is experiencing a surge in Covid-19 cases, primarily driven by the JN.1 Omicron sub-variant, prompting increased ...

Researchers discovered that COVID-19 and chronic hepatitis B share key genetic pathways related to the immune system. This ...

Explore how CRISPR could become a powerful antiviral tool against HIV, Hepatitis B, HPV, and more, based on emerging research.